ID: ALA5285878

Max Phase: Preclinical

Molecular Formula: C19H12O7

Molecular Weight: 352.30

Associated Items:

Representations

Canonical SMILES:  O=c1ccc2ccc(Cc3c(O)c4cc(O)c(O)cc4oc3=O)cc2o1

Standard InChI:  InChI=1S/C19H12O7/c20-13-7-11-16(8-14(13)21)26-19(24)12(18(11)23)5-9-1-2-10-3-4-17(22)25-15(10)6-9/h1-4,6-8,20-21,23H,5H2

Standard InChI Key:  BIILNDNTRBMXPU-UHFFFAOYSA-N

Associated Targets(Human)

DNA polymerase beta 23632 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.30Molecular Weight (Monoisotopic): 352.0583AlogP: 2.61#Rotatable Bonds: 2
Polar Surface Area: 121.11Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 2.21CX LogD: -0.14
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.37Np Likeness Score: 0.90

References

1. Faisal M, Saeed A, Shahzad D, Fattah TA, Lal B, Channar PA, Mahar J, Saeed S, Mahesar PA, Larik FA..  (2017)  Enzyme inhibitory activities an insight into the structure-Activity relationship of biscoumarin derivatives.,  141  [PMID:29032032] [10.1016/j.ejmech.2017.10.009]

Source